Literature DB >> 2918163

Hypertensive hypertrophic cardiomyopathy or hypertrophic cardiomyopathy with hypertension? A study of 78 patients.

R Karam1, H M Lever, B P Healy.   

Abstract

Hypertensive hypertrophic cardiomyopathy may be a distinctive cardiac condition resulting from hypertension. Alternatively, this disease may represent the coincidence of a common disease, hypertension, with a relatively rare cardiomyopathy. A consecutive series of patients with hypertrophic cardiomyopathy and hypertension were studied and compared with age- and gender-matched patients with cardiomyopathy alone. Thirty-nine patients were identified as having hypertension; they ranged in age from 31 to 84 years (average 60 +/- 13); 82% were greater than 50 years old; 18 (46%) were women. When these patients were compared with the age-matched group with hypertrophic cardiomyopathy alone, there were no clinical or electrocardiographic differences between the two groups. By echocardiography, the hypertensive and nonhypertensive groups had a similar incidence of systolic anterior motion (77 versus 64%, respectively), mitral annular calcification (31 versus 31%), septal thickness greater than 20 mm (56 versus 46%) and outflow tract gradient greater than 20 mm (59 versus 67%). A posterior wall thickness greater than 13 mm was more frequent in the hypertensive group (54%) compared with the nonhypertensive group (31%) (p = 0.02). The findings show that hypertrophic cardiomyopathy with associated hypertension is a disease of the elderly. But, with the exception of thicker walls, the clinical and echocardiographic features of the patients with hypertension were indistinguishable from those of the age-matched and, hence, elderly group of patients with cardiomyopathy without hypertension. These findings suggest that hypertension may make hypertrophy worse, but that it is not the primary cause of the cardiomyopathy. Thus, the condition might be better termed "hypertrophic cardiomyopathy with hypertension."

Entities:  

Mesh:

Year:  1989        PMID: 2918163     DOI: 10.1016/0735-1097(89)90596-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Hypertrophic cardiomyopathy in the elderly.

Authors:  L M Shapiro
Journal:  Br Heart J       Date:  1990-05

2.  The genetics of hypertrophic cardiomyopathy.

Authors:  D M Gilligan; J G Cleland; C M Oakley
Journal:  Br Heart J       Date:  1991-09

3.  Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy.

Authors:  Marco Canepa; Lars L Sorensen; Iraklis Pozios; Veronica L Dimaano; Hong-Chang Luo; Aurelio C Pinheiro; James B Strait; Claudio Brunelli; M Roselle Abraham; Luigi Ferrucci; Theodore P Abraham
Journal:  Am J Cardiol       Date:  2013-10-15       Impact factor: 2.778

Review 4.  Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly.

Authors:  Marco Canepa; Iraklis Pozios; Pier Filippo Vianello; Pietro Ameri; Claudio Brunelli; Luigi Ferrucci; Theodore P Abraham
Journal:  Heart       Date:  2016-04-27       Impact factor: 5.994

5.  Patients with small left ventricular size undergoing balloon aortic valvuloplasty have worse intraprocedural outcomes.

Authors:  Creighton Don; Pritha P Gupta; Christian Witzke; Manoj Kesarwani; Roberto J Cubeddu; Ignacio Inglessis; Igor F Palacios
Journal:  Catheter Cardiovasc Interv       Date:  2012-08-23       Impact factor: 2.692

6.  The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene.

Authors:  S al-Mahdawi; S Chamberlain; L Chojnowska; E Michalak; P Nihoyannopoulos; M Ryan; B Kusnierczyk; J A French; D M Gilligan; J Cleland
Journal:  Br Heart J       Date:  1994-08

Review 7.  Genetic, clinical, molecular, and pathogenic aspects of the South Asian-specific polymorphic MYBPC3Δ25bp variant.

Authors:  Mohammed Arif; Pooneh Nabavizadeh; Taejeong Song; Darshini Desai; Rohit Singh; Sholeh Bazrafshan; Mohit Kumar; Yigang Wang; Richard J Gilbert; Perundurai S Dhandapany; Richard C Becker; Evangelia G Kranias; Sakthivel Sadayappan
Journal:  Biophys Rev       Date:  2020-07-12

8.  Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity.

Authors:  James S Ware; Connie R Bezzina; Martin Farrall; Hugh Watkins; Andrew R Harper; Anuj Goel; Christopher Grace; Kate L Thomson; Steffen E Petersen; Xiao Xu; Adam Waring; Elizabeth Ormondroyd; Christopher M Kramer; Carolyn Y Ho; Stefan Neubauer; Rafik Tadros
Journal:  Nat Genet       Date:  2021-01-25       Impact factor: 38.330

9.  Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.

Authors:  Prathap Kanagala; Adrian S H Cheng; Anvesha Singh; John McAdam; Anna-Marie Marsh; Jayanth R Arnold; Iain B Squire; Leong L Ng; Gerry P McCann
Journal:  J Cardiovasc Magn Reson       Date:  2018-01-11       Impact factor: 5.364

10.  Pathway networks generated from human disease phenome.

Authors:  Ann G Cirincione; Kaylyn L Clark; Maricel G Kann
Journal:  BMC Med Genomics       Date:  2018-09-14       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.